SHENYANG, China, Sept. 7 /PRNewswire-Asia-FirstCall/ -- 3SBio Inc.
("3SBio") (Nasdaq:    SSRX), a leading China-based biotechnology company focused
on researching, developing, manufacturing and marketing biopharmaceutical
products today announced its planned participation in the following investor
conferences:

    Sep 9-10, 2010   Susquehanna Fourth Annual Beijing Management Summit
                     Beijing

    Sep 13-14, 2010  Morgan Stanley Global Healthcare Conference
                     NYC

    Oct 20-22, 2010  Citigroup Greater China Investor Conference
                     Macau

    Nov 1-2, 2010    Goldman Sachs China Investment Frontier Conference
                     Beijing

    Nov 3-5, 2010    Bank of America Merrill Lynch China Investment Summit
                     Beijing

    Nov 9-11, 2010   Morgan Stanley Asia Pacific Summit 2010
                     Singapore

Please see http://bbs.3sbio.com/en/News/xShowInfo_nnn6.aspx?ID=65 for further updates.

About 3SBio Inc.

3SBio is a leading, fully integrated, profitable biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products primarily in China. Its focus is on addressing large markets with significant unmet medical needs in nephrology, oncology, supportive cancer care, inflammation and infectious diseases. With headquarters and GMP certified manufacturing facilities in Shenyang, PRC, 3SBio employs over 500 people. Shares trade in the form of American Depositary Shares (ADSs) on the NASDAQ stock market under the ticker symbol "SSRX". Please see http://www.3SBio.com for more information.

    For more information, please contact:

    Investor Contacts
     Bo Tan
     Chief Financial Officer
     3SBio Inc.
     Tel:   +86-24-2581-1820
     Email: ir@3SBio.com

     Tom Folinsbee
     Director of Investor Relations
     3SBio Inc.
     Tel:   +852-8191-6991
     Email: ir@3SBio.com

SOURCE 3SBio Inc.

Back to top

RELATED LINKS
http://www.3SBio.com